It’s an exciting time in the retina field. Researchers at ARVO 2013 reported on newly identified genetic factors in AMD and novel treatments for the disease, as well as FDA approval of a retinal prosthesis for RP and a new anti-VEGF agent for wet
This year’s research includes studies on possible new dry eye indicators and treatments, contact lens solution efficacy and the lifelong impact of keratoconus.